Drug · DIN 02559684
ALYFTREK
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 31, 2025; first marketed July 31, 2025.
- Drug Identification Number (DIN)
- 02559684
- Company (DIN owner)
- Vertex Pharmaceuticals (Canada) IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Other respiratory system products R07AX
- Class
- Human
- Record last updated
- October 31, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VANZACAFTOR (VANZACAFTOR CALCIUM) | 10 MG | |
| TEZACAFTOR | 50 MG | |
| DEUTIVACAFTOR | 125 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 21, 2025: NOC 35709New Drug Submission (NDS)
Other DINs named ALYFTREK
- DIN 02559676 · Marketed